Literature DB >> 29599319

Aberrant Expression of PIWIL1 and PIWIL2 and Their Clinical Significance in Ductal Breast Carcinoma.

Monika Litwin1, Anna Szczepańska-Buda2, Dagmara Michałowska2, Jędrzej Grzegrzółka3, Aleksandra Piotrowska3, Agnieszka Gomułkiewicz3, Andrzej Wojnar4, Piotr Dzięgiel3,5, Wojciech Witkiewicz2.   

Abstract

BACKGROUND/AIM: P-Element-induced wimpy testis (PIWI) proteins in complex with PIWI-interacting RNA (piRNA) are involved in epigenetic regulation of gene expression in germline cells. Aberrant expression of piRNA and PIWI proteins have been identified in various types of tumour cells. The aim of this study was to evaluate the expression profiles of PIWI-like protein-1, -2 (PIWIL1 and PIWIL2), their immunohistochemical (IHC) characteristics in ductal breast cancer, and determine their correlation with clinicopathological parameters of this type of cancer.
MATERIALS AND METHODS: Material for IHC studies comprised of 101 invasive ductal carcinoma (IDC) cases and 31 mastopathy tissues. Frozen fragments of paired tissue specimens (tumour and adjacent non-malignant breast tissue) taken from 55 patients with IDC and 18 samples of mastopathy were used for molecular studies using real-time polymerase chain reaction (RT-PCR).
RESULTS: A statistically significantly higher level of PIWIL1 and PIWIL2 was found in IDC compared to mastopathy samples (p≤0.0001). Increased expression of PIWIL1 was correlated with increased PIWIL2 expression in breast cancer tissue. Surprisingly, PIWIL1 mRNA was detected only in cancer and mastopathy, but was not found in most normal breast tissues, although it is noteworthy that the PIWIL2 mRNA level was statistically significantly lower in mastopathy and IDC samples compared to normal breast tissues.
CONCLUSION: Our results affirm the hypothesis that reactivation of PIWI expression in various caner types is crucial for cancer development. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  PIWIL1; PIWIL2; breast cancer

Mesh:

Substances:

Year:  2018        PMID: 29599319     DOI: 10.21873/anticanres.12441

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  PIWIL1 interacting RNA piR-017061 inhibits pancreatic cancer growth via regulating EFNA5.

Authors:  Shen Xing; Jing Xie; Bo-Yong Shen; Hai-Tao Chen; Bin Sun; Zheng-Ting Wang; Jing-Wang Wang; Xiong-Xiong Lu
Journal:  Hum Cell       Date:  2021-01-03       Impact factor: 4.174

2.  [Cancer stem-like cell-derived exosomes promotes the proliferation and invasion of human umbilical cord blood-derived mesenchymal stem cells].

Authors:  Dan Zhang; Dawei He; Dian Li; Bo Tang; Dong Hu; Wenhao Guo; Zhang Wang; Lianju Shen; Guanghui Wei
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-12-30

Review 3.  The regulatory function of piRNA/PIWI complex in cancer and other human diseases: The role of DNA methylation.

Authors:  Dong-Dong Jia; Hui Jiang; Yi-Fei Zhang; Yu Zhang; Li-Li Qian; Yin-Feng Zhang
Journal:  Int J Biol Sci       Date:  2022-05-09       Impact factor: 10.750

Review 4.  The emerging role of the piRNA/piwi complex in cancer.

Authors:  Yongmei Liu; Mei Dou; Xuxia Song; Yanhan Dong; Si Liu; Haoran Liu; Jiaping Tao; Wenjing Li; Xunhua Yin; Wenhua Xu
Journal:  Mol Cancer       Date:  2019-08-09       Impact factor: 27.401

Review 5.  Critical Roles of PIWIL1 in Human Tumors: Expression, Functions, Mechanisms, and Potential Clinical Implications.

Authors:  Peixin Dong; Ying Xiong; Yosuke Konno; Kei Ihira; Daozhi Xu; Noriko Kobayashi; Junming Yue; Hidemichi Watari
Journal:  Front Cell Dev Biol       Date:  2021-02-26

6.  PIWIL1 Drives Chemoresistance in Multiple Myeloma by Modulating Mitophagy and the Myeloma Stem Cell Population.

Authors:  Yajun Wang; Lan Yao; Yao Teng; Hua Yin; Qiuling Wu
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

Review 7.  Elevated P-Element-Induced Wimpy-Testis-Like Protein 1 Expression Predicts Unfavorable Prognosis for Patients with Various Cancers.

Authors:  Kehua Jiang; Tao Ye; Juan Du; Lanlan Tang; Xiaolong Chen; Fa Sun; Xifeng Sun
Journal:  J Oncol       Date:  2021-12-31       Impact factor: 4.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.